Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Elevated levels of soluble ST2 protein in dengue virus infected patients.

Becerra A, Warke RV, de Bosch N, Rothman AL, Bosch I.

Cytokine. 2008 Feb;41(2):114-20. doi: 10.1016/j.cyto.2007.11.001. Epub 2008 Jan 28.

2.

Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation.

Houghton-Triviño N, Salgado DM, Rodríguez JA, Bosch I, Castellanos JE.

J Gen Virol. 2010 Mar;91(Pt 3):697-706. doi: 10.1099/vir.0.012971-0. Epub 2009 Nov 4.

PMID:
19889931
3.

High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue.

Guerrero CD, Arrieta AF, Ramirez ND, Rodríguez LS, Vega R, Bosch I, Rodríguez JA, Narváez CF, Salgado DM.

Cytokine. 2013 Mar;61(3):766-71. doi: 10.1016/j.cyto.2012.12.024. Epub 2013 Jan 26.

PMID:
23357301
4.

Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis.

Wagenaar JF, Gasem MH, Goris MG, Leeflang M, Hartskeerl RA, van der Poll T, van 't Veer C, van Gorp EC.

PLoS Negl Trop Dis. 2009 Jun 2;3(6):e453. doi: 10.1371/journal.pntd.0000453.

5.

Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease.

Kim DJ, Baek SY, Park MK, Park KS, Lee JH, Park SH, Kim HY, Kwok SK.

J Korean Med Sci. 2013 Aug;28(8):1145-53. doi: 10.3346/jkms.2013.28.8.1145. Epub 2013 Jul 31.

6.

Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis.

Ishikawa S, Shimizu M, Ueno K, Sugimoto N, Yachie A.

Cytokine. 2013 May;62(2):272-7. doi: 10.1016/j.cyto.2013.03.007. Epub 2013 Apr 3.

PMID:
23561929
7.

Characterization of interleukin-33 and soluble ST2 in serum and their association with disease severity in patients with chronic kidney disease.

Bao YS, Na SP, Zhang P, Jia XB, Liu RC, Yu CY, Mu SH, Xie RJ.

J Clin Immunol. 2012 Jun;32(3):587-94. doi: 10.1007/s10875-011-9622-7. Epub 2011 Dec 28.

PMID:
22203232
8.

Status of soluble ST2 levels in serum of HTLV-1 infected individuals.

Zahedi Avval F, Shomali S, Nadri M, Boostani R, Jarahi L, Youssefi M.

Acta Microbiol Immunol Hung. 2015 Jun;62(2):137-45. doi: 10.1556/030.62.2015.2.4.

PMID:
26132834
9.

IL-33/ST2 correlates with severity of haemorrhagic fever with renal syndrome and regulates the inflammatory response in Hantaan virus-infected endothelial cells.

Zhang Y, Zhang C, Zhuang R, Ma Y, Zhang Y, Yi J, Yang A, Jin B.

PLoS Negl Trop Dis. 2015 Feb 6;9(2):e0003514. doi: 10.1371/journal.pntd.0003514. eCollection 2015 Feb.

10.

Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus.

Mok MY, Huang FP, Ip WK, Lo Y, Wong FY, Chan EY, Lam KF, Xu D.

Rheumatology (Oxford). 2010 Mar;49(3):520-7. doi: 10.1093/rheumatology/kep402. Epub 2009 Dec 21.

11.

Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction.

Fousteris E, Melidonis A, Panoutsopoulos G, Tzirogiannis K, Foussas S, Theodosis-Georgilas A, Tzerefos S, Matsagos S, Boutati E, Economopoulos T, Dimitriadis G, Raptis S.

Cardiovasc Diabetol. 2011 Nov 21;10:101. doi: 10.1186/1475-2840-10-101.

12.

The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid.

Wakatabi K, Komine M, Meephansan J, Matsuyama Y, Tsuda H, Tominaga S, Ohtsuki M.

Eur J Dermatol. 2012 May-Jun;22(3):333-6. doi: 10.1684/ejd.2012.1706.

PMID:
22494834
13.

Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity.

Koraka P, Murgue B, Deparis X, Van Gorp EC, Setiati TE, Osterhaus AD, Groen J.

J Med Virol. 2004 Mar;72(3):445-50.

PMID:
14748068
14.

Elevated soluble thrombomodulin in the febrile stage related to patients at risk for dengue shock syndrome.

Butthep P, Chunhakan S, Tangnararatchakit K, Yoksan S, Pattanapanyasat K, Chuansumrit A.

Pediatr Infect Dis J. 2006 Oct;25(10):894-7.

PMID:
17006283
15.

Serum levels of soluble ST2 and interleukin-33 in patients with dermatomyositis and polymyositis.

Yuan L, Yao L, Zhao L, Xia L, Shen H, Lu J.

Clin Exp Rheumatol. 2013 May-Jun;31(3):428-32. Epub 2013 Mar 13.

PMID:
23485578
16.

Soluble ST2 plasma concentrations predict mortality in severe sepsis.

Hoogerwerf JJ, Tanck MW, van Zoelen MA, Wittebole X, Laterre PF, van der Poll T.

Intensive Care Med. 2010 Apr;36(4):630-7. doi: 10.1007/s00134-010-1773-0. Epub 2010 Feb 12.

17.

Reduced levels of interleukin 33 and increased levels of soluble ST2 in subjects with amyotrophic lateral sclerosis.

Lin CY, Pfluger CM, Henderson RD, McCombe PA.

J Neuroimmunol. 2012 Aug 15;249(1-2):93-5. doi: 10.1016/j.jneuroim.2012.05.001. Epub 2012 May 24.

PMID:
22633272
19.

Temporal changes of soluble ST2 after cardiovascular interventions.

Willems S, Sels JW, Flier S, Versteeg D, Buhre WF, de Kleijn DP, Hoefer IE, Pasterkamp G.

Eur J Clin Invest. 2013 Feb;43(2):113-20. doi: 10.1111/eci.12022. Epub 2012 Dec 6.

PMID:
23215810
20.

Elevated serum level of IL-33 and sST2 in patients with ankylosing spondylitis: associated with disease activity and vascular endothelial growth factor.

Li XL, Lin TT, Qi CY, Yuan L, Xia LP, Shen H, Lu J.

J Investig Med. 2013 Jun;61(5):848-51. doi: 10.231/JIM.0b013e31828deed2.

PMID:
23552178
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk